SAGIA classifies Sadara as strategic

Updated 21 June 2015
0

SAGIA classifies Sadara as strategic

Sadara Chemical Company (Sadara) has been classified as strategic by the Saudi Arabian General Investment Authority (SAGIA), the governmental entity established to oversee investment affairs in the Kingdom of Saudi Arabia. This puts Sadara in the highest classification category achievable under SAGIA’s current investment rankings.
This classification of Sadara’s investment status is in recognition of its commitment to enhancing the value of its investments in the petrochemical and chemical sectors of Saudi Arabia. This is also recognition of Sadara’s success in bringing associated investments into the Kingdom, providing significant employment opportunities for Saudi nationals, and driving further development of the industry or associated industries, according to SAGIA.
“We are pleased to have achieved the highest ranking with SAGIA and their recognition of Sadara’s positive impact on the Saudi economy,” said Ziad Al-Labban, CEO of Sadara. “We are driven by the support tendered to us by our stakeholders, Saudi Aramco and The Dow Chemical Company, and are committed to continuing to contribute to the enhancement and strengthening of the Kingdom’s value creation opportunities.”
“I would also like to thank SAGIA for its support of Sadara and its active role in helping the project achieve the successes it has to date,” Al-Labban added.
The evaluation criteria included a detailed appraisal of various aspects of Sadara and its business. This includes the transfer and localization of technological knowledge, diversification of the Kingdom’s economy, increasing exports and decreasing imports; developing local human resources, reinforcing and boosting the economic competitiveness of local products in both domestic and international markets, and encouraging balanced development of the various regions of the Kingdom.


CMRC admits first patients to new Saudi clinic

Updated 21 May 2019
0

CMRC admits first patients to new Saudi clinic

Cambridge Medical and Rehabilitation Center (CMRC), a top post-acute rehabilitation and long-term care facility in the UAE, has admitted 15 patients to its first medical facility in Saudi Arabia. 

CMRC’s new 60-bed clinic, located between Dhahran and Alkhobar, aims to help patients requiring post-acute care and rehabilitation services to make large improvements in their quality of life through multidisciplinary rehabilitative therapies including physiatry, physiotherapy, occupational therapy, speech and language therapy, and multi-sensory room sessions. 

The facility is staffed by multiple clinical experts including GPs, internal medicine consultants, pediatricians, ICU intensivists, rehabilitation consultants, psychologists and therapists, and will service patients across the eastern region of Saudi Arabia. 

It follows the same clinical procedures and protocols successfully implemented in facilities in the UAE, similarly benefiting from the center’s international partnership with the Spaulding Rehabilitation Network, a teaching affiliate of Harvard Medical School, and accreditations from Joint Commission International, CARF and Planetree.

FASTFACT

 

CMRC, a portfolio company of health care specialist investor TVM Capital Healthcare, also operates facilities in Abu Dhabi and Al-Ain in the UAE.

CMRC Group CEO Dr. Howard S. Podolsky said: “We expand into countries where there is notable demand for post-acute care and rehabilitation services. Like many countries around the world, Saudi Arabia is experiencing a rise in the incidence of non-communicable diseases, birth defects, and life-threatening injuries. Our new facility brings our world-class medical treatment, care, and rehabilitation therapies to the Kingdom through a truly patient-centric approach.”

He added: “We look forward to helping families in the region improve their quality of life and using our international expertise and specialized workforce to support the government of Saudi Arabia’s focus on health care development, as part of Saudi Vision 2030.” 

CMRC, a portfolio company of health care specialist investor TVM Capital Healthcare, also operates facilities in Abu Dhabi and Al-Ain in the UAE.

Dr. Helmut Schuehsler, CEO of TVM Capital Healthcare and board member of CMRC, said: “We believe that private equity investment should be a force for good, and that by working in health care, we have a real opportunity to make a difference to patients’ lives. Therefore, we conceptualized and invested in CMRC in the UAE to cater to those in need of post-acute care and an elevated level of rehabilitation. CMRC grew to be the leading post-acute care and rehabilitation provider in the UAE. We are very happy to bring the offer to the people of Saudi Arabia now.”

CMRC offers both inpatient services at its medical centers and outpatient therapy, where patients follow a rehabilitation program after discharge. The company employs more than 500 staff members across all facilities.